CID2136 - Physician's Weekly


Advertisement

CID2136

Factors in Daily Growth Hormone Adherence Identified

“Treatment of pediatric growth hormone deficiency (pGHD) involves daily injections of somatropin, a recombinant human growth hormone (r-hGH), administered subcutaneously,” explained the authors of a study published in Current...

GHI a Clinical Entity in Short Stature

Researchers have identified a wide spectrum of growth disorders—including several not previously considered part of the growth hormone insensitivity (GHI) spectrum—presenting analogously with short stature and normal GH...

Uncovering the Genetic Architecture of GHD Patients

Discrepancies between the laboratory testing and molecular diagnosis of GHD should be considered when seeking an accurate diagnosis of GHD, according to a study published in Frontiers in Endocrinology. To screen disease-causing...

MRI Is a Necessary Component in Evaluating Pediatric GHD

To avoid missing a tumor, the importance of administering MRI in children with pediatric growth hormone deficiency (GHD) and peak GH levels <5 ng/mL cannot be overemphasized, according to a study published in Growth Hormone...

Recognizing GHI As a Spectrum of Clinical Entities

There is a need to recognize growth hormone insensitivity (GHI) as a spectrum of clinical entities in undiagnosed short stature patients, according to a paper published in The Journal of Clinical Endocrinology and Metabolism....

Loading

Advertisement

For latest news and updates
Email-id is invalid